Glucose homeostasis and insulin resistance: prevalence, gender differences and predictors in adolescents

. 2014 ; 6 (1) : 100. [epub] 20140916

Status PubMed-not-MEDLINE Jazyk angličtina Země Velká Británie, Anglie Médium electronic-ecollection

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid25419241

BACKGROUND: Adolescence, due to transient pubertal insulin resistance (IR), is associated with a higher risk for disturbances of glucose metabolism. The aim of our study was 1) to investigate the prevalence of disturbances of glucose metabolism, 2) to define gender specific homeostasis model assessment of insulin resistance (HOMA-IR) thresholds associated with increased cardiometabolic risks and 3) to provide predictors of HOMA-IR. METHODS: The studied cohort consisted of Czech adolescents aged 13.0-17.9 years: 1,518 individuals of general population and three studied groups according weight category (615 normal weight, 230 overweight and 683 obese). The prevalence of IR, impaired fasting glucose (IFG) and type 2 diabetes was assessed. Risky HOMA-IR thresholds based on components of metabolic syndrome were investigated. HOMA-IR prediction was calculated taking into account age, blood pressure, multiple anthropometric, biochemical and hormonal parameters. RESULTS: In general population cohort, the prevalence of IFG and type 2 diabetes was 7.0% and <0.5%, respectively. Boys regardless of weight presented significantly higher levels of blood glucose and higher prevalence of IFG than girls. Obese boys were found more insulin resistant than obese girls. HOMA-IR thresholds of 3.6 for girls and 4.4 for boys were associated with increased cardiometabolic risks. For both genders, the model of HOMA-IR prediction was composed of age, BMI, ratio of free triiodthyronine to free thyroxine, gamma-glutamyltransferase activity and levels of triglycerides and sex hormone-binding globulin. CONCLUSIONS: The type 2 diabetes in adolescents, including those who were obese, was rarely diagnosed. Obese adolescent boys were at greater risk for IR and for IFG than obese girls. In adolescence, thresholds of HOMA-IR in contrast to predictors were found gender specific.

Zobrazit více v PubMed

Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care. 2006;29:2427–2432. doi: 10.2337/dc06-0709. PubMed DOI

Caprio S, Cline G, Boulware S, Permnente C, Shulman GI, Sherwin RS, Tamborlane WV. Effects of puberty and diabetes on metabolism of insulin-sensitive fuels. Am J Physiol. 1994;266:E885–E891. PubMed

Travers SH, Jeffers BW, Bloch CA, Hill JO, Eckel RH. Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children. J Clin Endocrinol Metab. 1995;80:172–178. PubMed

Moran A, Jacobs DR, Jr, Steinberger J, Hong C-P, Prineas R, Luepker RV, Sinaiko AR. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes. 1999;48:2039–2044. doi: 10.2337/diabetes.48.10.2039. PubMed DOI

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419. doi: 10.1007/BF00280883. PubMed DOI

Conwell LS, Trost SG, Brown WJ, Batch JA. Indexes of insulin resistance and secretion in obese children and adolescents: a validation study. Diabetes Care. 2004;27:314–319. doi: 10.2337/diacare.27.2.314. PubMed DOI

Haymond MW. Measuring insulin resistance: a task worth doing: but how? Pediatr Diabetes. 2003;4:115–118. doi: 10.1034/j.1399-5448.2003.00024.x. PubMed DOI

Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M. Homeostatic model assessment (HOMA) index cut off values to identify the metabolic syndrome in children. J Physiol Biochem. 2005;61:381–388. doi: 10.1007/BF03167055. PubMed DOI

Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–e503. doi: 10.1542/peds.2004-1921. PubMed DOI

Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M, Kendirici M, Keskin M, Kondolot M. Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods. J Clin Res Pediatr Endocrinol. 2010;2:100–106. doi: 10.4274/jcrpe.v2i3.100. PubMed DOI PMC

Rodden AM, Diaz VA, Mainous AG, 3rd, Koopman RJ, Geesey ME. Insulin resistance in adolescents. J Pediatr. 2007;151:275–279. doi: 10.1016/j.jpeds.2007.03.023. PubMed DOI

Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Racial (black-white) differences in insulin secretion and clearance in adolescents: The Bogalusa Heart Study. Pediatrics. 1996;97:357–360. PubMed

American Diabetes Association Standards of medical care in diabetes–2010. Diabetes Care. 2010;33(Suppl 1):S11–S61. doi: 10.2337/dc10-S011. PubMed DOI PMC

Williams DE, Cadwell BL, Cheng YJ, Cowie CC, Gregg EW, Geiss LS, Engelgau MM, Narayan KM, Imperatore G. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999–2000. Pediatrics. 2005;116:1122–1126. doi: 10.1542/peds.2004-2001. PubMed DOI

Writing Group for the SEARCH for Diabetes in Youth Study Group. Dabelea D, Bell RA, D’Agostino RB, Jr, Imperatore G, Johansen JM, Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ, Waitzfelder B. Incidence of diabetes in youth in the United States. JAMA. 2007;97:2716–2724. PubMed

Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Grüters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity – a problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004;151:199–206. doi: 10.1530/eje.0.1510199. PubMed DOI

Mazur A, Grzywa M, Małecka-Tendera E, Telega G. Prevalence of glucose intolerance in school age children. Population based cross-sectional study. Acta Paediatr. 2007;96:1799–1802. doi: 10.1111/j.1651-2227.2007.00553.x. PubMed DOI

Malecka-Tendera E, Erhardt E, Molnár D. Type 2 diabetes mellitus in European children and adolescents. Acta Paediatr. 2005;94:543–546. doi: 10.1080/08035250510026788. PubMed DOI

Lee S, Bacha F, Gungor N, Arslanian SA. Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr. 2006;148:188–194. doi: 10.1016/j.jpeds.2005.10.001. PubMed DOI

Xu L, Li M, Yin J, Cheng H, Yu M, Zhao X, Xiao X, Mi J. Change of body composition and adipokines and their relationship with insulin resistance across pubertal development in obese and nonobese Chinese children: the BCAMS study. Int J Endocrinol. 2012;2012:389108. doi: 10.1155/2012/389108. PubMed DOI PMC

Bush NC, Darnell BE, Oster RA, Goran MI, Gower BA. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes. 2005;54:2772–2778. doi: 10.2337/diabetes.54.9.2772. PubMed DOI

Lee S, Bacha F, Gungor N, Arslanian SA. Racial differences in adiponectin in youth: relationship to visceral fat and insulin sensitivity. Diabetes Care. 2006;29:51–56. doi: 10.2337/diacare.29.01.06.dc05-0952. PubMed DOI

Bacha F, Arslanian SA. Ghrelin suppression in overweight children: a manifestation of insulin resistance? J Clin Endocrinol Metab. 2005;90:2725–2730. doi: 10.1210/jc.2004-1582. PubMed DOI

Lambadiari V, Mitrou P, Maratou E, Raptis AE, Tountas N, Raptis SA, Dimitriadis G. Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes. Endocrine. 2011;39:28–32. doi: 10.1007/s12020-010-9408-3. PubMed DOI

Kobzova J, Vignerova J, Blaha P, Krejcovsky L, Riedlova J. The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Cent Eur J Public Health. 2004;12:126–130. PubMed

Aldhoon-Hainerová I, Zamrazilová H, Atkinson RL, Dušátková L, Sedláčková B, Hlavatý P, Lee ZP, Kunešová M, Hainer V. Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36. Int J Obes (Lond) 2014;38:285–291. doi: 10.1038/ijo.2013.72. PubMed DOI

Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care. 1996;19:1138–1141. doi: 10.2337/diacare.19.10.1138. PubMed DOI

Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683–689. doi: 10.2337/diacare.24.4.683. PubMed DOI

Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group The metabolic syndrome–a new worldwide definition. Lancet. 2005;366:1059–1062. doi: 10.1016/S0140-6736(05)67402-8. PubMed DOI

Hill M, Parízek A, Kancheva R, Dusková M, Velíková M, Kríz L, Klímková M, Pasková A, Zizka Z, Matucha P, Meloun M, Stárka L. Steroid metabolome in plasma from the umbilical artery, umbilical vein, maternal cubital vein and in amniotic fluid in normal and preterm labor. J Steroid Biochem Mol Biol. 2010;21:594–610. doi: 10.1016/j.jsbmb.2009.10.012. PubMed DOI

Brandou F, Brun JF, Mercier J. Limited accuracy of surrogates of insulin resistance during puberty in obese and lean children at risk for altered glucoregulation. J Clin Endocrinol Metab. 2005;90:761–767. doi: 10.1210/jc.2004-0329. PubMed DOI

Kuhl J, Hilding A, Ostenson CG, Grill V, Efendic S, Bavenholm P. Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity. Diabetologia. 2005;48:35–40. doi: 10.1007/s00125-004-1614-1. PubMed DOI

DECODE Study Group Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care. 2003;26:61–69. doi: 10.2337/diacare.26.1.61. PubMed DOI

Brufani C, Tozzi A, Fintini D, Ciampalini P, Grossi A, Fiori R, Kiepe D, Manco M, Schiaffini R, Porzio O, Cappa M, Barbetti F. Sexual dimorphism of body composition and insulin sensitivity across pubertal development in obese Caucasian subjects. Eur J Endocrinol. 2009;160:769–775. doi: 10.1530/EJE-08-0878. PubMed DOI

Yin J, Li M, Xu L, Wang Y, Cheng H, Zhao X, Mi J. Insulin resistance determined by Homeostasis Model Assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. 2013;15:71. doi: 10.1186/1758-5996-5-71. PubMed DOI PMC

Bosy-Westphal A, Geisler C, Onur S, Korth O, Selberg O, Schrezenmeir J, Müller MJ. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes (Lond) 2006;30:475–483. doi: 10.1038/sj.ijo.0803144. PubMed DOI

Bao W, Srinivasan SR, Berenson G. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults. The Bogalusa Heart Study. Circulation. 1996;93:54–59. doi: 10.1161/01.CIR.93.1.54. PubMed DOI

Kelishadi R, Cook SR, Amra B, Adibi A. Factors associated with insulin resistance and non-alcoholic fatty liver disease among youths. Atherosclerosis. 2009;204:538–543. doi: 10.1016/j.atherosclerosis.2008.09.034. PubMed DOI

Denzer C, Thiere D, Muche R, Koenig W, Mayer H, Kratzer W, Wabitsch M. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab. 2009;94:3872–3881. doi: 10.1210/jc.2009-1125. PubMed DOI

Mason JE, Starke RD, Van Kirk JE. Gamma-glutamyl transferase: a novel cardiovascular risk biomarker. Prev Cardiol. 2010;13:36–41. doi: 10.1111/j.1751-7141.2009.00054.x. PubMed DOI

Moriarty-Kelsey M, Harwood JE, Travers SH, Zeitler PS, Nadeau KJ. Testosterone, obesity and insulin resistance in young males: evidence for an association between gonadal dysfunction and insulin resistance during puberty. J Pediatr Endocrinol Metab. 2010;23:1281–1287. doi: 10.1515/jpem.2010.202. PubMed DOI PMC

Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003;149:331–335. doi: 10.1530/eje.0.1490331. PubMed DOI

Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, Wang F, Hull RL, Boyko EJ, Retzlaff BM, Walden CE, Knopp RH, Kahn SE. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005–1015. doi: 10.2337/diabetes.51.4.1005. PubMed DOI

Pannacciulli N, De Mitrio V, Marino R, Giorgino R, De Pergola G. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects. Obes Res. 2002;10:717–725. doi: 10.1038/oby.2002.98. PubMed DOI

Roef GL, Rietzschel ER, Van Daele CM, Taes YE, De Buyzere ML, Gillebert TC, Kaufman JM. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects. Thyroid. 2014;24:223–231. doi: 10.1089/thy.2013.0314. PubMed DOI PMC

Bouchalová M. Development during childhood and its influences: Brno growth study. Prague: Avicenum; 1987.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...